A virus-like-particle-producing DNA vaccine triggers specific humoral immunity against hepatitis C virus in mice
- 10 November 2025
- journal article
- research article
- Published by Springer Nature in Archives of Virology
- Vol. 170 (12) , 1-17
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Induction of neutralizing antibodies against hepatitis C virus by a subviral particle-based DNA vaccineAntiviral Research, 2022
- Listeriolysin O immunogenetic adjuvant enhanced potency of hepatitis C virus NS3 DNA vaccineIUBMB Life, 2019
- N-glycosylation-mutated HCV envelope glycoprotein complex enhances antigen-presenting activity and cellular and neutralizing antibody responsesBiochimica et Biophysica Acta (BBA) - General Subjects, 2016
- Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY‐3+)Hepatology, 2016
- Enhancement of immune response to a hepatitis C virus E2 DNA vaccine by an immunoglobulin Fc fusion tagJournal of Medical Virology, 2015
- New horizons in hepatitis C antiviral therapy with direct-acting antiviralsHepatology, 2013
- Interleukin-12 as a genetic adjuvant enhances hepatitis C virus NS3 DNA vaccine immunogenicityVirologica Sinica, 2013
- Construction of HCV-polytope vaccine candidates harbouring immune-enhancer sequences and primary evaluation of their immunogenicity in BALB/c miceVirus Genes, 2009
- HCV core protein immunization with Montanide/CpG elicits strong Th1/Th2 and long-lived CTL responsesBiochemical and Biophysical Research Communications, 2007
- Co‐delivery of GM‐CSF gene enhances the immune responses of hepatitis C viral core protein‐expressing DNA vaccine: Role of dendritic cellsJournal of Medical Virology, 2002